Request Demo
Last update 29 Nov 2025
SAL-0140
Last update 29 Nov 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms SAL 0140, SAL0140 |
Target |
Action antagonists |
Mechanism Aldosterone antagonists |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with SAL-0140NCT07051603
A Phase 1, Randomized, Double-Blind Placebo-Controlled Single and Multiple Dose Study Plus Food Effect Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of SAL0140 in Healthy Chinese Subjects
CTR20254681
评价不同剂量 SAL0140片治疗 2种或 3种及以上药物治疗且未控制的高血压患者的有效性和安全性的随机、双盲、安慰剂对照、多中心的Ⅱ期临床研究
[Translation] A randomized, double-blind, placebo-controlled, multicenter phase II clinical trial evaluating the efficacy and safety of different doses of SAL0140 tablets in patients with hypertension uncontrolled by two or more medications.
100 Clinical Results associated with SAL-0140
Login to view more data
100 Translational Medicine associated with SAL-0140
Login to view more data
100 Patents (Medical) associated with SAL-0140
Login to view more data
100 Deals associated with SAL-0140
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Resistant hypertension | Phase 2 | China | 25 Nov 2025 | |
| Chronic Kidney Diseases | IND Approval | China | 20 Nov 2025 | |
| Hyperaldosteronism | IND Application | China | 28 Sep 2025 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free